Tollys competitorsClear all
Tollys's top competitors include ChemoCentryx, Priothera, Remegen and GenFleet Therapeutics.
 Tollys Tollys is a biopharmaceutical company focused on innate immunity, particularly on the biology and modulation of the TLR3 receptor. |  ChemoCentryx ChemoCentryx is a biopharmaceutical company focused on the development and commercialization of medications targeting inflammatory disorders, autoimmune diseases, and cancer. |  Priothera Priothera is a company that develops receptor modulators intended to improve the lives of patients suffering from hematological malignancies. |  GenFleet Therapeutics GenFleet Therapeutics is a company that develops and researches molecular pharmaceuticals targeting cancer treatments. | ||
Founding Date | Founding Date 2015 | Founding Date 1997 | Founding Date 2020 | Founding Date 2008 | Founding Date 2017 |
Type | Type Private | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Lyon, FR HQ Lyon, FR | Locations San Carlos, US HQ | Locations Dublin, IE HQ | Locations Yantai, CN HQ | Locations CN HQ Shaoxing Shi, CN Shaoxing Shi, CN |
Employees | Employees N/A | Employees 13362% increase | Employees N/A | Employees 1501% decrease | Employees N/A |
Alexa Website Rank | Alexa Website Rank N/A | Alexa Website Rank 306523 | Alexa Website Rank 459900 | Alexa Website Rank 160580 | Alexa Website Rank 43054 |
Employee Rating | Employee Rating N/A | Employee Rating 2.9 | Employee Rating N/A | Employee Rating N/A | Employee Rating N/A |
Funding | |||||
Latest funding round | Latest funding round $ 2.5m (about 2 years ago) | Latest funding round N/A | Latest funding round $ 35.5m (over 1 year ago) | Latest funding round $ 100m (over 2 years ago) | Latest funding round $ 58m (over 2 years ago) |
Total funding raised | Total funding raised $ 6.8m | Total funding raised $ 149.5m | Total funding raised $ 35.5m | Total funding raised $ 100m | Total funding raised $ 89m |
For sources of this data, please see the company profile
View company profiles
ChemoCentryx
HQ
San Carlos, US
Employees
133
ChemoCentryx is a biopharmaceutical company focused on the development and commercialization of medications targeting inflammatory disorders, autoimmune diseases, and cancer.
View companyPriothera
HQ
Dublin, IE
Priothera is a company that develops receptor modulators intended to improve the lives of patients suffering from hematological malignancies.
View company
Remegen
HQ
Yantai, CN
Employees
150↓ 1% decrease
Remegen is a company that develops biopharmaceutical products.
View companyGenFleet Therapeutics
HQ
CN
GenFleet Therapeutics is a company that develops and researches molecular pharmaceuticals targeting cancer treatments.
View company